Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XANTUS-EL, Xarelto® on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Non-interventional Study

NCT01800006 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01800006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XANTUS-EL, Xarelto® on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Non-interventional Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 14, 2013
Completion date
June 20, 2016
Enrollment
2,101 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation